Orbital involvement in sickle cell disease: A systematic review.

Surv OphthalmolJun 3, 2026 (epub)
Clinical ResearchOphthalmologyHematology

Jai Paris, Abdullah I Almater, Charlotte Mackenzie et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review analyzed 76 cases of orbital involvement in sickle cell disease (SCD) from 53 studies. Predominantly affecting males with an average age of 13.2 years, the review highlighted that 6.6% presented with orbital disease as the initial SCD manifestation. Key findings included that 93.1% achieved complete recovery, emphasizing the importance of early recognition.

Key findings

  • Orbital disease was the initial SCD manifestation in 6.6% of cases.
  • 93.1% of patients achieved complete recovery.
  • Periorbital edema was present in all cases, with proptosis in 64.1% and restricted ocular motility in 56.5%.
  • Laboratory findings showed leukocytosis in 73% and raised inflammatory markers in 86.7%.

Why it matters

Understanding the manifestations of orbital involvement in sickle cell disease is crucial for timely diagnosis and management, as these complications can threaten vision. Early recognition can significantly improve patient outcomes.

Source

Published in Surv Ophthalmol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.